 | Up a level |
2018
Busch, L., Mougiakakos, D., Bach, C., Buettner-Herold, M., Bittenbring, J. T., Neumann, F., Beier, F., Bisht, S., Nolting, J., Boettcher, M., Pallasch, C., Boxhammer, R., Spriewald, B. M., Mackensen, A. and Bruns, H. (2018). Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway. Oncol. Res. Treat., 41. S. 187 - 189. BASEL: KARGER. ISSN 2296-5262
2017
Kraemer, I., Stilgenbauer, S., Dietrich, S., Boettcher, S., Bunjes, D. W., Zeis, M., Stadler, M., Bittenbring, J. T., Uharek, L., Scheid, C., Hegenbart, U., Ho, A., Anthony, D., Hallek, M., Kneba, M., Schmitz, N., Doehner, H. and Dreger, P. (2017). Long-term outcome of allogeneic hematopoietic stem cell transplantation (HSCT) for chronic lymphocytic leukemia (CLL): 10-year follow-up of the GCLLSG CLL3X trial. Bone Marrow Transplant., 52. S. S424 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
Rubbert-Roth, A., Bittenbring, J. T. and Assmann, G. (2017). Lymphoma in rheumatic diseases. Z. Rheumatol., 76. S. 46 - 57. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1435-1250
2014
Bruns, H., Bittenbring, J. T., Mougiakakos, D., Fabri, M., Buettner, M., Pasemann, S., Kempkes, B., Mackensen, A. and Gerbitz, A. (2014). Vitamin D-dependent induction of cathelicidin in human macrophages results in cytotoxicity against high grade B-cell lymphoma. Oncol. Res. Treat., 37. S. 70 - 71. BASEL: KARGER. ISSN 2296-5262